Feb. 13, 2023 Price forecast | 2 weeks: -0.55% | 1 month: -1.25% | 3 months: 0.82%

NBIX stock forecast

Our latest prediction for Neurocrine Biosciences, Inc.'s stock price was made on the Feb. 13, 2023 when the stock price was at 103.52$.

In the short term (2weeks), NBIX's stock price should underperform the market by -0.55%. During that period the price should oscillate between -4.53% and +3.90%.

In the medium term (3months), NBIX's stock price should outperform the market by 0.82%. During that period the price should oscillate between -19.66% and +14.15%.

Create a solid portfolio with NBIX

Add NBIX to your portfolio and optimize it!

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.

At the moment the company generates 71M USD in revenues.

On its last earning announcement, the company reported a profit of 1.61$ per share.

The book value per share is 4.17$

Neurocrine Biosciences, Inc. website

Three months stock forecastFeb. 13, 2023


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
71M 2061.58% 249M 350.27% 154M 1.61 - - 96M 4.17 - - -